PURCHASE ORDER
Active75F40126P00158
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$206.2K
obligated · signed 2 months ago
BORDETELLA-FREE BABOON STUDY
Performance timeline
Start
Aug 5, 2026
End
Aug 9, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Aug 9, 2027
THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER
Contract 75F40126P00158
UEI
S3GMKS8ELA16
Parent Company
THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER
Capabilities & Certifications
Headquarters Location
Congressional District: 09
Current Obligation
$206,192
Base + Exercised Options
$206,192
Total Ceiling Value
$272,301
Contract Type
FIRM FIXED PRICE
NAICS
ALL OTHER ANIMAL PRODUCTION
PSC
LIVE ANIMALS, NOT RAISED FOR FOOD
Place of Performance
Congressional District: 09
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.